Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival Correspondence

  

Authors:	Badar, T.; Atallah, E.; Shallis, R. M.; Goldberg, A. D.; Patel, A.; Abaza, Y.; Bewersdorf, J. P.; Saliba, A. N.; Correia, G. S. D. C.; Murthy, G.; Duvall, A.; Burkart, M.; Stahl, M.; Liu, Y.; Dinner, S.; Palmisiano, N.; Litzow, M. R.; Foran, J. M.
Title:	Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival
Keywords:	genetics; leukemia, myeloid, acute; hematopoietic stem cell transplantation; protein p53; tumor suppressor protein p53; tp53 protein, human; acute myeloid leukemia; humans; human
Journal Title:	American Journal of Hematology
Volume:	97
Issue:	7
ISSN:	0361-8609
Publisher:	John Wiley & Sons, Inc.
Date Published:	2022-07-01
Start Page:	E232
End Page:	E235
Language:	English
DOI:	10.1002/ajh.26546
PUBMED:	35338673
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85127372897&doi=10.1002%2fajh.26546&partnerID=40&md5=0a4e9570f4c43de796995b3db29525db
Notes:	Letter -- Export Date: 1 July 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/195568